Hematologic Cancer Clinical Trial John Stoddard Cancer Center

UnityPoint Clinic Urgent Care - Altoona

Closed Patients
Waiting Now

UnityPoint Clinic Urgent Care - Ingersoll

Closed Patients
Waiting Now

Urgent Care - Ankeny

Closed Patients
Waiting Now

Urgent Care - Lakeview

Closed Patients
Waiting Now

Urgent Care - Merle Hay

Closed Patients
Waiting Now

Urgent Care - Southglen

Closed Patients
Waiting Now

Urgent Care - Urbandale

Closed Patients
Waiting Now

Hematologic Cancer Research Studies

CML 

EA9171: A Phase II Study of adding the anti-PD-1 antibody pembrolizumab to tyrosine kinase inhibitors in patients with chronic myeloid leukemia and persistently detectable minimal residual disease 

CLL 

EA9161: A Randomized Phase III Study of the addition of Venetoclax to Ibrutinib and Obinutuzumab versus Ibrutinib and Obinutuzumab in Untreated Younger Patients with Chronic Lymphocytic Leukemia (CLL)  

B-CELL LYMPHOMA 

ADCT-402-201: A Phase 2 Open-Label Single-Arm Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)  

B-CELL ALL

A041501: A Phase III Trial to Evaluate the Efficacy of the Addition of Inotuzumab Ozogamicin (a Conjugated Anti-CD22 Monoclonal Antibody) to Frontline Therapy in Young Adults (Ages 18-39 Years) with Newly Diagnosed Precursor B-Cell ALL 

MDS 

NHLBI-MDS: The National Myelodysplastic Syndromes Natural History Study  

AML/MDS

S1612: A Randomized Phase II/III Trial of "Novel Therapeutics" versus Azacitidine in Newly Diagnosed Patients with Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS), Age 60 or Older  

FOLLICULAR LYMPHOMA 

S1608: Randomized Phase II Trial in Early Relapsing or Refractory Follicular Lymphoma 

SMOLDERING MYELOMA 

EAA173: Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)  

Cancer Care Delivery Research Studies 

A231602CD: Assessing Financial Difficulty in Patients with Blood Cancers